Abstracts of the World Congress of Enhanced Recovery after Surgery and Perioperative Medicine, Washington, DC, USA, May 9-12, 2015
Ulf Gustafsson,Henrik Oppelstrup,Olle Ljungqvist,Anders Thorell,Jonas Nygren,Larissa A. Meyer,Alpa M. Nick,Maria D. Iniesta,Qiuling Shi,Lakisha D Washington,M. Harris,Lindsay Palmer,Katherine E. Cain,Terri Earles,Javier Lasala,Xin Wang,Pedro T. Ramírez,Jakob Stenseth,Nicolò Pecorelli,Julio F. Fiore,Benjamin Mappin‐Kasirer,Petru Niculiseanu,Chelsia Gillis,Rashami Awasthi,Francesco Carli,Liane S. Feldman,Frédèric Michard,William K. Mountford,Michelle R. Krukas,Frank R. Ernst,Sandy Fogel,Nader Francis,Lison Luther,Emad Salib,Lucy Allenby,D. Messenger,Andrew Allison,Neil Smart,Jonathan Ockrim,Shu Zhang,Gang Wang,Zhiwei Jiang,Kun Zhao,Jieshou Li,Natasha Joshi,T. Batchelor,Neil Rasburn,M. Molyneux,Kajan Kamalanathan,Douglas West,Gianluca Casali,Rakesh Krishnadas,N. Wharton
DOI: https://doi.org/10.1007/s12630-015-0372-5
2015-01-01
Abstract:Objectives: There is evidence that surgical stress can influence oncological outcome and survival (1).This study investigated if increased adherence to the ERAS (Enhanced Recovery After Surgery) protocol, designed to reduce perioperative stress (2), is associated with increased long-term survival after surgery for colorectal cancer.Methods: Between the years 2002-2007, 911 consecutive patients, operated with major colorectal cancer surgery at Ersta Hospital, Stockholm, Sweden were analyzed according to adherence to twelve pre-and perioperative ERAS protocol interventions.The histopathological report of the resected specimen, date and cause of death of the patients as well as post-operative CRP levels were obtained.The relation between the rate of adherence to the ERAS-protocol and five-year overall and colorectal cancer specific survival was determined.Results: Increased adherence to ERAS-interventions was significantly associated with improved 5-year cancer specific survival in the group with adherence C 70% (N = 273, p \ 0.001).In Cox regression, correcting for confounding, the risk of cancer specific death was improved 42%, HR 0.58 (0.39-0.88) in this group compared to all other patients.With low adherence, \ 50% (n = 317), the risk of cancer death increased by 83%, HR 1.83 (1.16-2.88)compared to the group with C 70 adherence.Significant independent predictors of increased 5-year survival were: avoiding overload of intravenous fluids, HR 0.528 (0.32-0.86) and oral intake, HR 0.55 (0.34-0.78) on the day of operation.Also, increased CRP post-operative day 1 (POD1) was found as an independent predictor for decreased 5-year survival.Patients with C 70% adherence had a lower CRP, POD1 compared to all other patients, mean SD 72 ± 36 vs. 85 ± 41 (p \ 0.001).Conclusion: Increased adherence to the ERAS-protocol is associated with increased 5year cancer specific survival after colorectal cancer surgery.